WHO ICTRP trial
To compare the efficacy and safety of BCD-055 (CJSC BIOCAD, Russia) and…
CTRI/2017/03/008063 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2017/03/008063 |
|---|---|
| Public title | To compare the efficacy and safety of BCD-055 (CJSC BIOCAD, Russia) and Remicade® with methotrexate in patients with rheumatoid arthritis |
| Scientific title | International comparative multicenter double-blind randomized clinical study of efficacy and safety of BCD-055 (CJSC BIOCAD, Russia) and Remicade® in combination with methotrexate in patients with active rheumatoid arthritis |
| Primary sponsor | BIOCAD INDIA PVT LTD |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India;Russian Federation |
| Conditions | Health Condition 1: null- Patients with diagnosis of active rheumatoid arthritis |
| Interventions | Intervention1: BCD-055-3(Infliximab manufactured by CJSC BIOCAD Russia): In the study, after signing the Informed Consent and completing screening procedures, patients will be stratified and randomly assigned (randomized) to receive BCD-055… |
| Registration date | Oct 3, 2017 |
| Target size | 426 |
| Secondary IDs | BCD-055-3/LIRA Version 1.1 dated 17.03.2016 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: